MedTrace Logo

Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients

NCT05619575 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-08-22

Study results available
· View outcomes & findings →

Summary

Acceptance and performance of the CP1170 sound processor in experienced adult cochlear implant recipients compared with the CP1150 sound processor and their current sound processor.

Conditions

Interventions

DEVICE

CP1170 Sound Processor

The CP1170 Sound Processor will be used to determine the hearing performance with the new implementation of ForwardFocus in SCAN 2 (SCAN 2 FF), as assessed by speech perception in noise.

DEVICE

CP1150 Sound Processor

Active comparator off-the-ear sound processor.

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • Cochlear

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-20
Primary Completion
2023-09-07
Completion
2024-01-10

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05619575 on ClinicalTrials.gov